Clinical and laboratory characteristics in patients with essential thrombocythemia, according to pattern of c-mplexpression
Characteristic . | All patients, n = 88 . | Pattern of c-mpl expression . | P . | ||
---|---|---|---|---|---|
Uniform; n = 28, 32% of all . | Heterogeneous-moderate; n = 30, 34% of all . | Heterogeneous-weak; n = 30, 34% of all . | |||
Sex: M/F (ratio) | 39/49 (0.79) | 11/17 (0.64) | 15/15 (1.00) | 13/17 (0.76) | .691 |
Median age, y (range) | 53 (16-84) | 53 (22-80) | 56 (19-84) | 48 (16-77) | .405 |
Median Hb, g/L (range) | 13.9 (102-186) | 139 (102-175) | 136 (112-186) | 140 (108-164) | .928 |
Median Hct (range) | 0.42 (0.3-0.55) | 0.42 (0.3-0.52) | 0.41 (0.32-0.55) | 0.42 (0.37-0.48) | .954 |
Median PLT count, 109/L (range) | 775 (350-1673)* | 747 (505-1415) | 780 (601-1673) | 793 (350-1600)* | .212 |
Median WBC count, 109/L (range) | 8.5 (4.8-28.8) | 7.7 (4.8-12.0) | 8.6 (5.1-16.8) | 8.9 (5.5-28.8) | .045 |
No. BM hypercellularity (%) | 56 (64) | 13 (46) | 23 (77) | 20 (67) | .052 |
No. with splenomegaly (%)† | 25 (28) | 5 (18) | 13 (43) | 7 (23) | .074 |
No. with thrombosis (%) | 20 (23) | 2 (7) | 5 (17) | 13 (43) | .020 |
Characteristic . | All patients, n = 88 . | Pattern of c-mpl expression . | P . | ||
---|---|---|---|---|---|
Uniform; n = 28, 32% of all . | Heterogeneous-moderate; n = 30, 34% of all . | Heterogeneous-weak; n = 30, 34% of all . | |||
Sex: M/F (ratio) | 39/49 (0.79) | 11/17 (0.64) | 15/15 (1.00) | 13/17 (0.76) | .691 |
Median age, y (range) | 53 (16-84) | 53 (22-80) | 56 (19-84) | 48 (16-77) | .405 |
Median Hb, g/L (range) | 13.9 (102-186) | 139 (102-175) | 136 (112-186) | 140 (108-164) | .928 |
Median Hct (range) | 0.42 (0.3-0.55) | 0.42 (0.3-0.52) | 0.41 (0.32-0.55) | 0.42 (0.37-0.48) | .954 |
Median PLT count, 109/L (range) | 775 (350-1673)* | 747 (505-1415) | 780 (601-1673) | 793 (350-1600)* | .212 |
Median WBC count, 109/L (range) | 8.5 (4.8-28.8) | 7.7 (4.8-12.0) | 8.6 (5.1-16.8) | 8.9 (5.5-28.8) | .045 |
No. BM hypercellularity (%) | 56 (64) | 13 (46) | 23 (77) | 20 (67) | .052 |
No. with splenomegaly (%)† | 25 (28) | 5 (18) | 13 (43) | 7 (23) | .074 |
No. with thrombosis (%) | 20 (23) | 2 (7) | 5 (17) | 13 (43) | .020 |